TapImmune Appoints Frederick G. Wasserman to its Board of Directors

Life Science Investing News

TapImmune Inc. (OTCMKTS: TPIV) has appointed Frederick G. Wasserman to its Board as an Independent Director.

TapImmune Inc. (OTCMKTS: TPIV) has appointed Frederick G. Wasserman to its Board as an Independent Director.
According to the company press release:

Frederick (Rick) is an accomplished Board Director with 35 years of business experience. He has served during his career as President, COO and CFO of entrepreneurial, middle-market companies. Rick has a strong financial background which he has successfully focused on all aspects of company operations including cash flow, profitability and equity valuation.  He has served as a member of Audit and Corporate Governance Committees for public companies in the U.S. and Europe. In his role as President of FGW Partners LLC,Pennington, New Jersey, he has assisted small and micro-cap companies at transitional points in their evolutions.  This has included focus on corporate governance, investment analysis and liquidity management, as well as general financial and operational issues.

Click here to view the full press release. 

The Conversation (0)
×